AtaiBeckley (ATAI) EBITDA (2020 - 2026)
AtaiBeckley's (ATAI) quarterly EBITDA came in at -$30.9 million in Q1 2026, down 51.7% year-on-year from -$64.0 million in Q1 2025, and down 51.7% quarter-over-quarter from -$20.4 million in Q1 2025.
AtaiBeckley (ATAI) EBITDA (2020 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 6 years of EBITDA data on file, last reported at -$28.4 million in Q3 2025.
- For the quarter ending Q3 2025, EBITDA fell 25.81% year-over-year to -$28.4 million; the trailing twelve-month figure through Sep 2025 stood at -$104.3 million (up 1.54% YoY), and the FY2024 full-year result was -$102.7 million, up 18.16% from the prior year.
- EBITDA slipped to -$30.9 million in Q1 2026 per ATAI's latest filing, from -$20.4 million in the prior quarter.
- Across five years, EBITDA topped out at -$20.4 million in Q1 2025 and bottomed at -$30.9 million in Q1 2026.
- A 5-year average of -$30.7 million and a median of -$31.9 million in 2023 frame the typical range for EBITDA.
- Peak annual rise in EBITDA reached 48.22% in 2021, while the deepest fall reached 952.69% in 2021.
- Tracing ATAI's EBITDA over 5 years: stood at -$45.2 million in 2021, then climbed by 16.85% to -$37.6 million in 2022, then grew by 10.66% to -$33.6 million in 2023, then climbed by 9.82% to -$30.3 million in 2024, then advanced by 6.04% to -$28.4 million in 2025.
- Business Quant data shows ATAI's EBITDA at -$28.4 million in Q3 2025, -$25.3 million in Q2 2025, and -$20.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | -28.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.90 Mn |
| Sep 30, 2025 | -28.44 Mn |
| Jun 30, 2025 | -25.27 Mn |
| Mar 31, 2025 | -20.37 Mn |
| Mar 31, 2025 | -20.37 Mn |
| Dec 31, 2024 | -30.27 Mn |
| Sep 30, 2024 | -22.60 Mn |
| Jun 30, 2024 | -25.73 Mn |
| Mar 31, 2024 | -24.09 Mn |
| Dec 31, 2023 | -33.56 Mn |
| Sep 30, 2023 | -26.83 Mn |
| Jun 30, 2023 | -31.86 Mn |
| Mar 31, 2023 | -33.21 Mn |
| Dec 31, 2022 | -37.57 Mn |
| Sep 30, 2022 | -38.42 Mn |
| Jun 30, 2022 | -35.36 Mn |
| Mar 31, 2022 | -33.44 Mn |
| Dec 31, 2021 | -45.18 Mn |
| Sep 30, 2021 | -33.36 Mn |
| Jun 30, 2021 | -61.32 Mn |